Price increases are the biggest driver of rising emergency room visit costs across the U.S., according to research led by the Center for Health and Biosciences' Vivian Ho and Sasathorn Tapaneeyakul.
Companies developing stem cell-based interventions should work with policymakers and patient advocates to address risks for current and future patients and to protect clinical research and the reputation of the field, write the authors. Read their full article in Cell & Gene Therapy Insights (free registration).
"The COVID-19 effect is likely to reduce the demand for public transport in favor of lower density alternatives," write the authors. Their study considers links between commuters' demographic factors and incidence of disease transmission, as well as the environmental implications of decreased ridership on public transport.
Kenneth B. Medlock III, Ted Loch-Temzelides, Shih Yu (Elsie) HungNovember 4, 2021
"In the U.S., Latinos are disproportionately affected by the COVID-19 pandemic. A critical step to reduce the spread of COVID-19 is diagnostic testing," write scholar Luz Garcini and co-authors. This research article identifies the barriers and facilitators that must be addressed in order to implement accessible, effective testing.
Luz Maria Garcini, Tommy Tam Pham, Arlynn Ambriz, Sarah Lill, Joel TsevatOctober 31, 2021
The authors identify mental health stressors and strategies for coping with distress among underserved Latino communities during the COVID-19 pandemic.
Luz Maria Garcini, Jason Rosenfield, Garrett Kneese, Ruth Bondurant, Kathryn KanzlerApril 24, 2021
It now seems technically feasible to culture human embryos beyond the “fourteen‐day limit,” which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. Robust stakeholder engagement preceded adoption of the fourteen‐day limit and should arguably be part of efforts to reassess it, write the authors.
Kirstin R.W. Matthews, Ana S. Iltis, Daniel S. Wagner, Nuria Gallego Marquez, Jason Scott Robert, Inmaculada de Melo-Martín, Marieke Bigg, Sarah Franklin, Soren Holm, Ingrid Metzler, Matteo A. Molè, Jochen Taupitz, Giuseppe Testa, Jeremy SugarmanFebruary 26, 2021
This study leverages validated patient-reported outcomes measures to analyze the association between "financial toxicity" and quality of life and satisfaction among women undergoing ablative breast cancer surgery. Journal of the American College of Surgeons
Anaeze C. Offodile II, Christopher J. Coroneos, Yu-Li Lin, Chris Sidey-Gibbons, Malke Asaad, Brian Chin, Stefanos Boukovalas, Margaret S. Roubaud, Makesha Miggins, Donald P. BaumannDecember 21, 2020
The results of this study suggest that Medicare Data on Provider Practice and Specialty, which costs less to obtain than from a for-profit data source, can be used to reliably track the cost and quality effects of vertical integration between hospitals and physicians.